Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Share Issue/Capital Change 2025

Jun 14, 2025

30528_rns_2025-06-14_a0e065ed-13eb-4f4c-af47-45e396a58732.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: [email protected] Web: www.drreddys.com

June 14, 2025

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY) BSE Ltd. (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs

This is to inform you that the Company has allotted 57,885 equity shares of Re.1/- each of the Company, fully paid up, on June 14, 2025, to eligible employees pursuant to exercise of their Stock Options under Dr. Reddy's Employees Stock Options Scheme, 2002 and Dr. Reddy's Employees ADR Stock Options Scheme, 2007.

Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Thanking you.

Yours faithfully, For Dr. Reddy's Laboratories Limited

K Randhir Singh KUMAR RANDHIR SINGH Digitally signed by KUMAR RANDHIR SINGH Date: 2025.06.14 15:25:35 +05'30'

Company Secretary, Compliance Officer & Head-CSR

Encl: as above

Dr. Reddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: [email protected] Web: www.drreddys.com

Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

1 Company name and address of Registered Office:
Dr. Reddy's Laboratories Limited
8-2-337, Road No.3, Banjara Hills, Hyderabad – 500034
2 Name of the Stock Exchanges on which the company's shares are listed:
BSE Limited
National Stock Exchange of India Limited
New York Stock Exchange Inc. (ADRs)
NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee
Benefits) Regulations, 2021 with Stock Exchange:
The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and
Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were
filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat
Equity) Regulations, 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any:
Dr. Reddy's Employees Stock Options Scheme, 2002
Dr. Reddy's Employees ADR Stock Options Scheme, 2007
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Re. 1/-
8 Date of issue of shares: June 14, 2025 (Date of allotment on exercise)
9 Number of shares issued: 57,885 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 834513206 to 834571090
12 ISIN Number of the shares if issued in Demat: INE089A01031
13 Exercise price per share:
i.43,320 equity shares exercised at Re.1/- per share
ii.155 equity shares exercised at Rs. 1,060.2/- per share
iii.8,160 equity shares exercised at Rs. 781.2/- per share
14 iv.6,250 equity shares exercised at Rs. 521.4/- per sharePremium per share:
i.43,320 equity shares- Nil
ii.155 equity shares - 1,059.2/- per shares
iii.8,160 equity shares - 780.2/- per share
iv.6,250 equity shares - 520.4/- per share
15 Total Issued shares after this issue: 83,45,72,090 (*)
16 Total Issued share capital after this issue: Rs. 83,45,72,090/-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical?
Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA

(*) Total paid up capital after this issue: 83,45,71,090 equity shares of Re.1 each, aggregating to Rs. 83,45,71,090 (difference of 1,000 due to forfeited shares of Re. 1/- each in September 1988 on account of nonpayment of allotment money.)

KUMAR RANDHIR SINGH Digitally signed by KUMAR RANDHIR SINGH Date: 2025.06.14 15:25:59 +05'30'